According to the argument, surveys produce valid results, while RCTs produce invalid results.

As is so often the case, the answer is money.

"The FDA erred in concluding that current, ongoing financial relationships with drug manufacturers did not constitute a conflict. Since manufacturers of smoking-cessation drugs compete with manufacturers of DTPs, ... and since Dr. Benowitz stood to profit from the sale of NRT drugs, he faced a conflict with regard to providing advice in the TPSAC's report on DTPs. ... the TPSAC was charged with studying the public health impact of a drug (i.e., DTPs), and Dr. Benowitz had an ongoing business relationship (i.e., consulting work) with companies developing "alternative" or competing drugs (i.e., smoking-cessation drugs). Accordingly, I find that the FDA's conclusion with regard to Dr. Benowitz was a 'clear error of judgment.'"

The AHA’s need to issue a policy statement on e-cigarettes comes in response to the skyrocketing use of these devices. As of early 2014, there were an estimated 466 brands and 7764 different flavors of e-cigarette products. With all of these products in the marketplace, critics are concerned with the danger of youth use, often citing that the flavors and packaging of these devices and e-liquids are making nicotine use more attractive for kids & teenagers. In 2012 data from the showed that only 2.1% of kids in grade 6-12 use e-cigarettes, however this number is up from the previous year. Seventy-six percent of youth who have tried e-cigarettes also smoke traditional cigarettes. This seems to suggest that despite many critics’ concerns, e-cigarettes aren’t necessarily the “gateway” to smoking that some people originally thought.

LAST：2014 Newest Electronic Cigarette H2 Atomizer |NEXT：Kingway PATENT 2014 innovative bluetooth electronic cigarette Vshare wholesale